Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a biopharmaceutical company focused on pioneering cell therapy platforms for cancer, autoimmune, and infectious ...

BTIG analyst Julian Harrison has maintained their bullish stance on SYRE stock, giving a Buy rating on January 14.Invest with Confidence: ...

Celldex Therapeutics , Inc. (NASDAQ:CLDX), a biopharmaceutical company with a market capitalization of $1.6 billion focused on developing innovative therapies for challenging diseases, has been making ...

Coeptis Therapeutics Holdings Inc., a biopharmaceutical company focused on pioneering cell therapy platforms for cancer, ...

Coya Therapeutics (COYA) announced the expansion of its investigational pipeline and advancement of COYA 303 for the treatment of inflammatory ...

Digital therapeutics allow health care workers and patients to use software in the management and treatment of disease. The ...

NDAQ:HOTH) Hoth Therapeutics Expands Intellectual Property Portfolio with Acquisition of New Patent Applications ...

Avacta Therapeutics has reported outcomes from the Phase Ia trial of AVA6000, a drug candidate for solid tumours.

The Global Ophthalmic Disease Therapeutics market showcased growth ... healthcare infrastructure are anticipated to propel market expansion. The rising incidence of lifestyle-related eye diseases ...

The FDA’s decision marks J&J's Spravato as the first monotherapy for adults with treatment-resistant depression.

DelveInsight's 'Tuberculosis Pipeline Insight 2025' report provides comprehensive global coverage of pipeline tuberculosis ...

Relay Therapeutics (market cap: $748.2 million), a biotechnology company focused on developing innovative cancer therapies, ...